Bortezomib alters sour taste sensitivity in mice

Chemotherapy-induced taste disorder is one of the critical issues in cancer therapy. Bortezomib, a proteasome inhibitor, is a key agent in multiple myeloma therapy, but it induces a taste disorder. In this study, we investigated the characteristics of bortezomib-induced taste disorder and the underl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohishi, Akihiro, Nishida, Kentaro, Miyamoto, Karin, Imai, Mizuka, Nakanishi, Ryoko, Kobayashi, Kyoko, Hayashi, Akiko, Nagasawa, Kazuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615125/
https://www.ncbi.nlm.nih.gov/pubmed/28959638
http://dx.doi.org/10.1016/j.toxrep.2017.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615125/
https://www.ncbi.nlm.nih.gov/pubmed/28959638
http://dx.doi.org/10.1016/j.toxrep.2017.03.003

Ejemplares similares